• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Ag Ord (OP:BAYZF)

    51.95 +3.17 (+6.50%)
    Streaming Delayed Price Updated: 3:57 PM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Bayer Ag Ord

    News headline image
    Bayer Accelerates Pharma Growth on High-Value Portfolio
    From Bayer
    Via Business Wire
    News headline image
    Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
    From Bayer
    Via Business Wire
    News headline image
    Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference
    From Bayer
    Via Business Wire
    News headline image
    Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
    From Bayer
    Via Business Wire
    News headline image
    RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
    From Bayer
    Via Business Wire
    News headline image
    Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
    From Bayer
    Via Business Wire
    News headline image
    Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
    From Bayer
    Via Business Wire
    News headline image
    Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
    From Bayer
    Via Business Wire
    News headline image
    U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
    From Bayer
    Via Business Wire
    News headline image
    Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
    From Bayer
    Via Business Wire
    News headline image
    KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
    From Bayer
    Via Business Wire
    News headline image
    Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
    From Bayer
    Via Business Wire
    News headline image
    Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
    From Bayer
    Via Business Wire
    News headline image
    Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
    From Bayer
    Via Business Wire
    News headline image
    One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
    From Bayer
    Via Business Wire
    News headline image
    BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
    From Bayer
    Via Business Wire
    News headline image
    Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
    From Bayer
    Via Business Wire
    News headline image
    Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
    From Bayer
    Via Business Wire
    News headline image
    Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
    From Bayer
    Via Business Wire
    News headline image
    10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
    From Bayer
    Via Business Wire
    News headline image
    Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
    From Bayer
    Via Business Wire
    News headline image
    Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
    From Bayer
    Via Business Wire
    News headline image
    Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
    From Bayer
    Via Business Wire
    News headline image
    OTC Markets Group Welcomes Bayer AG to OTCQX
    From OTC Markets
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.